Clinical Trial Update: Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors [Phase 1]

View source ↗

Summary

Completed Phase 1 dose-escalation trial evaluating the combination of gemcitabine and ON-01910.Na in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• Gemzar (gemcitabine)
• ON-01910.Na (ON-01910 sodium)

Snippet

Sponsor: Traws Pharma, Inc. | Conditions: Malignant Neoplasmas, Solid Tumors | Phase 1 | Status: COMPLETED